Cancer Vaccines Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Increasing Recognition of Immunotherapy as a Transformative Approach in Cancer Treatment
   3. Market Restraints
      1. Intricacy of Tumor Heterogeneity
      2. Confined Success in Solid Tumor Types
   4. Market Opportunity
      1. Exploration and Development of Next-Generation Vaccines Targeting a Broader Spectrum of Cancers
   5. Market Trends
      1. Advancements in Personalized Cancer Vaccines
      2. Combination Therapies with Immune Checkpoint Inhibitors
5. MARKET SEGMENTATION
   1. By Vaccine Type
      1. Preventive Cancer Vaccines
      2. Therapeutic Cancer Vaccines
      3. Others
   2. By Indication Type
      1. Prostate Cancer
      2. Bladder Cancer
      3. Melanoma
      4. Cervical Cancer
      5. Other
   3. By Technology Type
      1. Recombinant Cancer Vaccines
      2. Whole-cell Cancer Vaccines
      3. Viral Vector and DNA Cancer Vaccines
      4. Other Technologies
   4. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Amgen Inc.
      2. AbbVie Inc.
      3. Astrazeneca
      4. Advaxis, Inc
      5. Allergan
      6. Boehringer Ingelheim International GmbH
      7. BioNTech SE
      8. Cardinal Health
      9. CureVac AG
      10. Celldex Therapeutics
      11. F. Hoffmann-La Roche Ltd
      12. GSK plc
      13. Genocea
      14. Gritstone Oncology
      15. Johnson & Johnson Services, Inc.
      16. Mylan N.V.
      17. Merck & Co., Inc.
      18. Moderna, Inc.
      19. Novartis AG
      20. Personalis Inc.
      21. Pfizer Inc.
      22. Sanofi
      23. Sun Pharmaceutical Industries Ltd.
      24. Teva Pharmaceutical Industries Ltd.
      25. Takeda Pharmaceutical Company Limited.

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global Cancer Vaccines market?

The global market of Cancer Vaccines is projected to reach USD 18.98 Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Cancer Vaccines market?

The global Cancer Vaccines market has an estimated annual growth rate of 9.3%.

Q.3. What are the recent trends of Cancer Vaccines market?

Advancements in personalized cancer vaccines and combination therapies with immune checkpoint inhibitorsare some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Cancer Vaccines?

The major companies profiled in this report include Amgen Inc., AbbVie Inc., Astrazeneca, Advaxis, Inc, Allergan, Boehringer Ingelheim International GmbH, BioNTech SE, Cardinal Health, CureVac AG, Celldex Therapeutics, F. Hoffmann-La Roche Ltd, GSK plc, Genocea, Gritstone Oncology, Johnson & Johnson Services, Inc., Mylan N.V., Merck & Co., Inc., Moderna, Inc., Novartis AG, Personalis Inc., Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited. among others.

Q.5. Which is the largest regional market in the Cancer Vaccines?

North America is the largest regional market for Cancer Vaccines.